CytRx Corporation Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 16 of 20 Posts
1 2
Top Performing Stocks In January And Seasonality
Article By: Cory Mitchell, CMT Sunday, December 31, 2017 11:33 AM EDT
January is not a good month for the stock market overall. The S&P 500 is usually flat to lower during the month. BUT, there are individual stocks that excel in January, rising at least 70% of the time and producing up to 17% gains during the month.
In this article: ALK, DIS, HRS, LEN, FAX, ALKS, CRUS, ERIC, XLNX, CYTR, EQC, OSK
Read
Incyte Rises After ASCO Abstracts, But Piper Urges Closer Look
Article By: The Fly Wednesday, May 17, 2017 9:48 PM EDT
The release of study abstracts for next month's ASCO conference drove significant moves tonight in drugmakers, but Piper Jaffray urged caution on the company's data, saying its "not sure what other investors are seeing that we aren't."
In this article: MRK, INCY, NLNK, AMGN, NKTR, CYTR, BLUE, LBIO, LPTX
Read
E Cytrx Shares Fall 66% After Phase 3 Sarcoma Trial Failure
Article By: Terry Chrisomalis Tuesday, July 12, 2016 8:51 AM EDT
The phase 3 trial recruited up to 433 patients to be treated for second-line soft tissue sarcoma. Shares of the company tumbled as data released showed that patients taking Aldoxorubicin failed to improve.
In this article: CYTR
Read
Tuesday Morning Pre-Market Insights: TSLA, SHAK, CYTR, EXAS
Article By: TipRanks Tuesday, July 21, 2015 9:26 AM EDT
Tesla Motors Inc. shares fell nearly -5% in pre-market trading after the company received a downgrade from Colin Langan at UBS. The analyst lowered his price target on the stock from $220 to $210.
In this article: CYTR, EXAS, GPRO, TSLA
Read
Cytrx Corporation Announces That FDA Has Removed Partial Clinical Hold For Cancer Drug
Article By: Terry Chrisomalis Tuesday, January 20, 2015 11:55 AM EDT
Trials currently in phase 2 testing Aldoxorubicin in cancer patients have a partial clinical hold lifted.
In this article: CYTR
Read
Cytrx Reports Positive Phase 2 Results In Patients With Brain Cancer Using Aldoxorubicin
Article By: Terry Chrisomalis Tuesday, January 6, 2015 4:17 PM EDT
CYTR shares soar 20% on positive Phase 2 results
In this article: CYTR
Read
E Small Cap Best & Worst Report - December 18, 2014
Article By: E.B. Capital Markets Thursday, December 18, 2014 8:56 AM EDT
The average small cap score is 53.03, below the four week moving average score of 54.71.
In this article: FARO, ANGO, ETM, EVOL, NTRI, ISSC, NAII, AIQ, CDE, CYTR
Read
E Small Cap Best And Worst Report - December 11, 2014
Article By: E.B. Capital Markets Thursday, December 11, 2014 9:03 AM EDT
The average small cap score is 56.63, above the four week moving average score of 54.79. The average small cap stock is trading -26.35% below its 52 week high, 0.43% above its 200 dma, and has 7.89 days to cover held short.
In this article: AIQ, CMN, GSS, ANAC, AVID, CFNL, DRYS, ISSC, NTRI, CYTR
Read
E Small Cap Best & Worst Report - December 4, 2014
Article By: E.B. Capital Markets Thursday, December 4, 2014 9:09 AM EDT
The average small cap score is 53.38, below the four week moving average score of 54.27.
In this article: AIQ, CDE, CMN, EBS, ANAC, BELFB, CMTL, DRYS, CYTR, ESMC
Read
CYTR Receives Written FDA Communication Regarding Partial Clinical Hold For Aldoxorubicin; GHDX Predicts Outcomes In Prostate Cancer Patients
Article By: BioMedReports Thursday, December 4, 2014 3:29 AM EDT
CYTR announced that its clinical trials for aldoxorubicin have been placed on partial clinical hold. GHDX announced results from two studies of the Oncotype DX® prostate cancer test.
In this article: GHDX, CYTR
Read
E Small Cap Best & Worst Report: Turkey Day Edition - November 27, 2014
Article By: E.B. Capital Markets Thursday, November 27, 2014 11:58 AM EDT
The average small cap score is 55.20, above the four week moving average score of 54.98.
In this article: CDE, ANAC, BELFB, BGFV, CENT, NTRI, RSTI, CYTR, ESMC, FORD
Read
E Small Cap Best & Worst Report - November 20, 2014
Article By: E.B. Capital Markets Thursday, November 20, 2014 9:16 AM EDT
The average small cap score is 53.77, below the four week moving average score of 53.89.
In this article: AIQ, CDE, EBS, ANAC, BELFB, CENT, DRYS, NTRI, PENN, RSTI, ARWR, CYTR
Read
CytRx Announces Partial Clinical Hold On Main Drug - Big Buying Opportunity For Investors
Article By: Terry Chrisomalis Tuesday, November 18, 2014 2:36 PM EDT
Aldoxorubicin receives a partial clinical hold from the FDA.
In this article: CYTR
Read
E Small Cap Best And Worst Report - November 13, 2014
Article By: E.B. Capital Markets Thursday, November 13, 2014 9:05 AM EDT
The average small cap score is 54.59, above the four week moving average score of 53.22. The average small cap is trading -27.26% below its 52 week high, 0.86% above its 200 dma, and has 9.05 days to cover held short.
In this article: AIQ, CDE, MEI, XOXO, ANAC, BELFB, DRYS, NTRI, ARWR, CYTR
Read
E Small Cap Best And Worst Report - October 30, 2014
Article By: E.B. Capital Markets Thursday, October 30, 2014 8:29 AM EDT
The average small cap score is 51.03, above the four week moving average score of 49.21. The average small cap stock is trading -30% below its 52 week high, -5.52% below its 200 dma, and has 9.05 days to cover held short.
In this article: AIQ, CMN, ETH, ORB, ANAC, RGEN, SIGA, DRYS, CYTR, ESMC
Read
E Small Cap Report
Article By: E.B. Capital Markets Friday, May 2, 2014 5:28 AM EDT
The average score across our small cap universe is 44.67, below the 4 week moving average score of 46.75. The average small cap is trading -26.28% below its 52 week high, -3.69% below its 200 dma, and has 6.77 days to cover held short.
In this article: CIR, EPL, EVC, EXAM, FSS, GB, GBX, GDP, DRRX, DXPE, NVAX, QQQ, SIFY, SIMO, SWHC, CYTR, SPY
Read
1 to 16 of 20 Posts
1 2